Albert C. Ludolph

Active 1986–2026

Also published as
Albert C Ludolph
375
Papers
39,705
Citations
113
h-index
354
i10-index

Citations

Citations per year for Albert C. Ludolph1951: 3 citations1967: 1 citations1977: 1 citations1983: 1 citations1986: 2 citations1987: 13 citations1988: 14 citations1989: 29 citations1990: 27 citations1991: 13 citations1992: 21 citations1993: 27 citations1994: 15 citations1995: 17 citations1996: 19 citations1997: 25 citations1998: 22 citations1999: 31 citations2000: 51 citations2001: 50 citations2002: 51 citations2003: 73 citations2004: 53 citations2005: 77 citations2006: 116 citations2007: 107 citations2008: 112 citations2009: 149 citations2010: 180 citations2011: 160 citations2012: 189 citations2013: 196 citations2014: 255 citations2015: 287 citations2016: 423 citations2017: 454 citations2018: 459 citations2019: 1,419 citations2020: 1,832 citations2021: 1,852 citations2022: 1,604 citations2023: 1,436 citations2024: 2,300 citations2025: 1,223 citations2026: 36 citations1952–1966: no citations, so these years are not shown1968–1976: no citations, so these years are not shown1978–1982: no citations, so these years are not shown1984–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,751 citing papers, 21.4% of this breakdownUnited Kingdom: 1,648 citing papers, 9.4% of this breakdownGermany: 1,576 citing papers, 9% of this breakdownItaly: 1,205 citing papers, 6.9% of this breakdownChina: 1,081 citing papers, 6.2% of this breakdownFrance: 712 citing papers, 4.1% of this breakdownAustralia: 651 citing papers, 3.7% of this breakdownCanada: 644 citing papers, 3.7% of this breakdownNetherlands: 610 citing papers, 3.5% of this breakdownSpain: 532 citing papers, 3% of this breakdownSweden: 524 citing papers, 3% of this breakdownJapan: 406 citing papers, 2.3% of this breakdown
0%21.4%Other 23.8%

Fields

  • Medicine64.8%
  • Biochemistry, Genetics and Molecular Biology16%
  • Neuroscience14.4%
  • Immunology and Microbiology1.3%
  • Psychology0.5%
  • Health Professions0.4%
  • Other2.6%

Topics

  • Amyotrophic Lateral Sclerosis Research13.5%
  • Neurogenetic and Muscular Disorders Research6.9%
  • Parkinson's Disease Mechanisms and Treatments5.5%
  • Alzheimer's disease research and treatments5.4%
  • Genetic Neurodegenerative Diseases3.8%
  • Neuroinflammation and Neurodegeneration Mechanisms3.2%
  • Other61.7%

Coauthors

All papers

Open in search
  1. Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2022 cited by 850

  2. Blood GFAP as an emerging biomarker in brain and spinal cord disorders

    Authors: , , , , , , , , , , , , , - Nature Reviews Neurology 2022 cited by 812

  3. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bradley Smith, Marta Gromicho, Siddharthan Chandran, Suvankar Pal, Karen Morrison, Pamela J. Shaw, John Hardy, Richard W. Orrell, Michael Sendtner, Thomas Meyer, Nazlı Başak, Anneke J. van der Kooi, Antonia Ratti, Isabella Fogh, Cinzia Gellera, Giuseppe Lauria, Stefania Corti, Cristina Cereda, Daisy Sproviero, Sandra D’Alfonso, Gianni Sorarú, Gabriele Siciliano, Massimiliano Filosto, Alessandro Padovani, Adriano Chiò, Andrea Calvo, Cristina Moglia, Maura Brunetti, Antonio Canosa, Maurizio Grassano, Ettore Beghi, Elisabetta Pupillo, Giancarlo Logroscino, Beatrice Nefussy, Alma Osmanovic, Angelica Nordin, Yossef Lerner, Michal Zabari, Marc Gotkine, Robert H. Baloh, Shaughn Bell, Patrick Vourc’h, Philippe Corcia, Philippe Couratier, Stéphanie Millecamps, Vincent Meininger, François Salachas, Jesús S. Mora Pardina, Abdelilah Assialioui, Ricardo Rojas-García, Patrick A. Dion, Jay P. Ross, Albert C. Ludolph, Jochen H. Weishaupt, Dávid Brenner, Axel Freischmidt, Gilbert Bensimon, Alexis Brice, Alexandra Durr, C. Payán, Safa Saker-Delye, Nicholas Wood, Simon Topp, Rosa Rademakers, Lukas Tittmann, Wolfgang Lieb, André Franke, Stephan Ripke, Alice Braun, Julia Kraft and 182 more - Nature Genetics 2021 cited by 552

  4. Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2023 cited by 318

  5. Stages of pTDP‐43 pathology in amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , - Annals of Neurology 2013 cited by 1,066

  6. Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer’s Disease and Correlates with Cognitive Impairment

    Authors: , , , , , , , , , , , , , - Journal of Alzheimer s Disease 2018 cited by 360

  7. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philippe Corcia, Philippe Couratier, Markus Weber, Julian Großkreutz, Albert C. Ludolph, Susanne Petri, Mamede de Carvalho, Philip Van Damme, Kevin Talbot, Martin R. Turner, Pamela J. Shaw, Ammar Al‐Chalabi, Adriano Chiò, Orla Hardiman, Karel G.M. Moons, Jan H. Veldink, Leonard H. van den Berg - The Lancet Neurology 2018 cited by 517

  8. Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Neurology 2022 cited by 191

  9. Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andreas Hermann, Christoph Kleinschnitz - The Lancet Neurology 2020 cited by 349

  10. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander E. Volk, Petri Kursula, Karin M. Danzer, Peter Lichtner, Ivan Đikić, Thomas Meitinger, Albert C. Ludolph, Tim M. Strom, Peter M. Andersen, Jochen H. Weishaupt - Nature Neuroscience 2015 cited by 783

  11. Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , - Journal of Neurology Neurosurgery & Psychiatry 2018 cited by 276

  12. Serum GFAP differentiates Alzheimer’s disease from frontotemporal dementia and predicts MCI-to-dementia conversion

    Authors: , , , , , , , , , , , , , , , , - Journal of Neurology Neurosurgery & Psychiatry 2022 cited by 94

  13. Amyotrophic lateral sclerosis—a model of corticofugal axonal spread

    Authors: , , , , , - Nature Reviews Neurology 2013 cited by 530

  14. Effects of tofersen treatment in patients with SOD1-ALS in a “real-world” setting – a 12-month multicenter cohort study from the German early access program

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin Jentsch, Thomas Haarmeier, Patrick Weydt, Ivan Valkadinov, Jasper Hesebeck‐Brinckmann, Julian Conrad, Jochen H. Weishaupt, Peggy Schumann, Peter Körtvélyessy, Thomas Meyer, Wolfgang Ruf, Simon Witzel, Makbule Şenel, Hayrettin Tumani, Albert C. Ludolph - EClinicalMedicine 2024 cited by 105

  15. Inflammatory dysregulation of blood monocytes in Parkinson’s disease patients

    Authors: , , , , , , , , , , , , - Acta Neuropathologica 2014 cited by 297

  16. Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Neurology Neurosurgery & Psychiatry 2015 cited by 322

  17. TDP-43 is intercellularly transmitted across axon terminals

    Authors: , , , , , , , , , , , - The Journal of Cell Biology 2015 cited by 324

  18. Increased Immune Activation by Pathologic α‐Synuclein in Parkinson's Disease

    Authors: , , , , , , , , , , , , , , - Annals of Neurology 2019 cited by 162

  19. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andreas Hermann - Nature Communications 2018 cited by 290

  20. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frank Baas, Anneke J. van der Kooi, Marianne de Visser, Anneloor L.M.A. ten Asbroek, Peter C. Sapp, Diane McKenna‐Yasek, Meraida Polak, Seneshaw Asress, José Luís Muñoz-Blanco, Tim M. Strom, Thomas Meitinger, Karen Morrison, Giuseppe Lauria, Kelly L. Williams, P. Nigel Leigh, Garth A. Nicholson, Ian P. Blair, Claire S. Leblond, Patrick A. Dion, Guy A. Rouleau, Hardev Pall, Pamela J. Shaw, Martin R. Turner, Kevin Talbot, Franco Taroni, Khrista Boylan, Marka van Blitterswijk, Rosa Rademakers, Jesús Esteban‐Pérez, Alberto García‐Redondo, Phillip Van Damme, Wim Robberecht, Adriano Chiò, Cinzia Gellera, Carsten Drepper, Michael Sendtner, Antonia Ratti, Jonathan D. Glass, Jesús S. Mora, Nazlı Başak, Orla Hardiman, Albert C. Ludolph, Peter M. Andersen, Jochen H. Weishaupt, Robert H. Brown, Ammar Al‐Chalabi, Vincenzo Silani, Christopher E. Shaw, Leonard H. van den Berg, Jan H. Veldink, John E. Landers - Nature Genetics 2016 cited by 294

  21. Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Neurology 2017 cited by 214

  22. Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis

    Authors: , , , , , - Acta Neuropathologica 2019 cited by 128

  23. A revision of the El Escorial criteria - 2015

    Authors: , , , , , , , - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2015 cited by 478

  24. Skeletal muscle in amyotrophic lateral sclerosis

    Authors: , , , , , , , , , - Brain 2023 cited by 90